| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely to therapy and endocrinology, and concerns hypertension treatments in women in combination with hormone replacement therapy. That is ensured by introduction of Drospirenone (DRSP) in amount 0.5-3 mg/day and 17-estradiol in amount 1-3 mg/day. ^ EFFECT: invention provides maximally effective arterial pressure reduction with minimum by-effects in given category of patients. ^ 17 cl, 3 ex, 1 tbl, 8 dwg
|
